FemHealth Ventures

All recorded activity

By stage

Series A2

Series C+1

Healthtech2

Biotech1

United States3

3 in all activity

Jun 16

Develops a hydrogel system to treat uterine health conditions and prevent scarring

$25MSeries A

Role not disclosed

Jun 9

Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors

$100MSeries E

Role not disclosed

May 6

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

$48MSeries A

Role not disclosed